Similar Items: Patenting Proteomics
- Patent Strategy in Pharmaceutical Industry: Are additional patents valuable?
- Patents and Public Health
- Patents in the Food Sector
- Patentability Requirements for Nanotechnological Inventions
- Second Generation Patents in Pharmaceutical Innovation
- Patentability of Chemical Selection Inventions: The Olanzapine and Escitalopram Decisions
Topic: K1-7720
Topic: Markenrecht
- The Scope and Limits of Protection for Distinctive Signs against the Community Design
- Contextual Brand Valuation
- Patents and Public Health
- The United States Bayh-Dole Act and its Effect on University Technology Transfer
- Enforcement of FRAND Commitments under Article 102 TFEU
- The Role of Standard-Setting Organizations with Regard to Balancing the Rights Between the Owners and the Users of Standard-Essential Patents